• Home
  • About Us
  • Visa Services
    • Work and Skilled Visas
      • Skilled Independent (Subclass 189)
      • Skilled Nominated (Subclass 190)
      • Skilled Work Regional (Subclass 491)
      • Skilled Graduate (Subclass 485)
      • Skilled Regional (Subclass 887)
      • Temporary Skill Shortage (Subclass 482)
      • Employer Nomination Scheme (Subclass 186)
      • Skilled Employer Sponsored Regional (Subclass 494)
      • Temporary Activity (Subclass 408)
      • Temporary Graduate (Subclass 485)
      • Distinguished Talent (Subclass 124)
      • Distinguished Talent (Subclass 858)
    • Other Visa Services
      • Australia Visa
      • AAT Appeals
      • Citizenship
      • Partner Visa
      • Skill Assessment
      • Visitor Visa
    • Citizen & other visa
      • Canada Student Visa
      • New Zealand Student Visa
      • USA Student Visa
      • UK Student Visa
    • Student & Training Visa
      • Student Visa (Subclass 500)
      • Training (Subclass 407)
    • Visitor & Tourist visa
      • Visitor Visa (Subclass 600)
      • ETA (Subclass 601)
      • eVisitor (Subclass 651)
      • Work And Holiday (Subclass 462)
      • Working Holiday (Subclass 417)
    • Family & Partner visa
      • Partner (Subclass 820/801)
      • Partner (Subclass 309/100)
      • Prospective Marriage (Subclass 300)
  • Points Calculator
  • Student Services
    • Admissions And Course Change
    • Professional Year
    • Temporary Graduate Visa (Subclass 485)
    • Education
      • IELTS
      • TOEFL
      • OET
      • PTE
  • Migration
    • Australia Student Visa
    • Canada Student Visa
    • New Zealand Student Visa
    • UK Student Visa
    • USA Student Visa
  • Blog
  • Contact
    NEED HELP? CALL US OR WHATSAPP NOW +61 432676982
    info@localhost
    visajunction1@gmail.com
    Visa JunctionVisa Junction
    • Home
    • About Us
    • Visa Services
      • Work and Skilled Visas
        • Skilled Independent (Subclass 189)
        • Skilled Nominated (Subclass 190)
        • Skilled Work Regional (Subclass 491)
        • Skilled Graduate (Subclass 485)
        • Skilled Regional (Subclass 887)
        • Temporary Skill Shortage (Subclass 482)
        • Employer Nomination Scheme (Subclass 186)
        • Skilled Employer Sponsored Regional (Subclass 494)
        • Temporary Activity (Subclass 408)
        • Temporary Graduate (Subclass 485)
        • Distinguished Talent (Subclass 124)
        • Distinguished Talent (Subclass 858)
      • Other Visa Services
        • Australia Visa
        • AAT Appeals
        • Citizenship
        • Partner Visa
        • Skill Assessment
        • Visitor Visa
      • Citizen & other visa
        • Canada Student Visa
        • New Zealand Student Visa
        • USA Student Visa
        • UK Student Visa
      • Student & Training Visa
        • Student Visa (Subclass 500)
        • Training (Subclass 407)
      • Visitor & Tourist visa
        • Visitor Visa (Subclass 600)
        • ETA (Subclass 601)
        • eVisitor (Subclass 651)
        • Work And Holiday (Subclass 462)
        • Working Holiday (Subclass 417)
      • Family & Partner visa
        • Partner (Subclass 820/801)
        • Partner (Subclass 309/100)
        • Prospective Marriage (Subclass 300)
    • Points Calculator
    • Student Services
      • Admissions And Course Change
      • Professional Year
      • Temporary Graduate Visa (Subclass 485)
      • Education
        • IELTS
        • TOEFL
        • OET
        • PTE
    • Migration
      • Australia Student Visa
      • Canada Student Visa
      • New Zealand Student Visa
      • UK Student Visa
      • USA Student Visa
    • Blog
    • Contact

      public

      • Home
      • Blog
      • public
      • Coronavirus disease 2019

      Coronavirus disease 2019

      COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

      The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

      COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

      Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

      Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

      • Share:
      author avatar
      zetgifari

      Previous post

      A böngészős kaszinó élmény
      23/09/2026

      Next post

      Yukon Gold Casino Security and Responsible Gaming Features for Canadian Players
      23/09/2026

      Search

      [INSERT_ELEMENTOR id=”8920″]

      Copyright @2020, Visa Junction.